What are the marketed Prophylactic vaccine drugs?

Marketed Prophylactic vaccine drugs include Flu Vaccine, Recombinant Human Papillomavirus Bivalent Vaccine, Human Papillomavirus, HPV vaccine.

Prophylactic vaccine

4 marketed 7 in Phase 3

This page covers all Prophylactic vaccine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Influenza A and B viral hemagglutinin and neuraminidase surface antigens, Human papillomavirus types 16 and 18 (HPV-16, HPV-18), Human Papillomavirus capsid protein (L1).

Targets

Influenza A and B viral hemagglutinin and neuraminidase surface antigens · Human papillomavirus types 16 and 18 (HPV-16, HPV-18) · Human Papillomavirus capsid protein (L1) · Human papillomavirus (HPV) capsid proteins / L1 antigen · HPV-16 and HPV-18 L1 capsid proteins · Human papillomavirus types 16 and 18 · HPV-16 and HPV-18 L1 capsid protein · HPV type 16 and 18 L1 capsid protein · Human papillomavirus (HPV) types 6, 11, 16, 18 · Human papillomavirus (HPV) types 16 and 18

Marketed (4)

Flu Vaccine · La Fundacion Favaloro para la Investigacion y la Docencia Medica · Immunology
Recombinant Human Papillomavirus Bivalent Vaccine · National Cancer Institute (NCI) · Oncology / Immunology
This vaccine stimulates the immune system to produce antibodies against two types of human papillomavirus (HPV-16 and HPV-18) to prevent infection and cervical cancer development.
Human Papillomavirus · Peking Union Medical College Hospital · Oncology / Immunology / Infectious Disease
Human Papillomavirus (HPV) vaccines stimulate the immune system to produce antibodies against specific HPV types, preventing infection and associated cancers.
HPV vaccine · Fondazione IRCCS Policlinico San Matteo di Pavia · Oncology / Immunology / Infectious Disease
HPV vaccine stimulates the immune system to produce antibodies and cellular immunity against human papillomavirus types that cause cervical and other cancers.

Phase 3 pipeline (7)

HPV-16/18 vaccine · Shanghai Zerun Biotechnology Co.,Ltd · Oncology / Immunology
This vaccine stimulates the immune system to produce antibodies and cellular immunity against human papillomavirus types 16 and 18, preventing infection and associated cancers.
CervarixTM · GlaxoSmithKline · Oncology / Immunology
Cervarix is a bivalent human papillomavirus (HPV) vaccine that stimulates the immune system to produce antibodies against HPV types 16 and 18, preventing infection and cervical cancer development.
HPV-16/18 L1 VLP AS04 · GlaxoSmithKline · Oncology / Immunology
This vaccine stimulates the immune system to produce antibodies against HPV-16 and HPV-18 virus-like particles, preventing infection and cervical cancer development.
GSK580299 (Cervarix) · GlaxoSmithKline · Oncology / Immunology
Cervarix is a bivalent human papillomavirus (HPV) vaccine that stimulates the immune system to produce antibodies against HPV types 16 and 18, preventing infection and cervical cancer development.
Licensed quadrivalent HPV vaccine, Gardasil · Murdoch Childrens Research Institute · Oncology / Immunology
Gardasil is a quadrivalent vaccine that stimulates the immune system to produce antibodies against four types of human papillomavirus (HPV types 6, 11, 16, and 18).
CervarixTM (GSK580299) · GlaxoSmithKline · Oncology / Immunology
Cervarix is a bivalent human papillomavirus (HPV) vaccine that stimulates the immune system to produce antibodies against HPV types 16 and 18, which cause cervical cancer.
Cervarix TM · GlaxoSmithKline · Oncology / Immunology
Cervarix is a bivalent human papillomavirus (HPV) vaccine that stimulates the immune system to produce antibodies against HPV types 16 and 18, preventing infection and cervical cancer development.